Finance

Lists
IDXG:OTCMKTS
Interpace Biosciences Inc
$6.47
0.00%
(0.00) 1D
Sep 22, 2:10:25 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IDXG...
Mkt. cap
32.69M
Avg. vol.
2.36K
Volume
0.00
P/E ratio
1.47
52-wk high
$39.25
52-wk low
$5.97
EPS
$4.41
Beta
0.61
Shares outstanding
5.54M
No. of employees
102
Mkt. cap
32.69M
Avg. vol.
2.36K
Volume
0.00
P/E ratio
1.47
52-wk high
$39.25
52-wk low
$5.97
EPS
$4.41
Beta
0.61
Shares outstanding
5.54M
No. of employees
102
News stories
From web sources and news partners
About Interpace Biosciences Inc
CEO-
Employees102
Founded1986
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorHealth care provider
Websiteinterpace.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.76M
9.22M
9.03M
9.13M
Cost of goods sold
3.32M
3.18M
3.13M
3.48M
Cost of revenue
3.32M
3.18M
3.13M
3.48M
Research and development expenses
150.00K
142.00K
153.00K
149.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.14M
3.62M
4.63M
5.18M
Operating expense
4.29M
3.77M
4.78M
5.33M
Total operating expenses
7.61M
6.95M
7.91M
8.81M
Operating income
1.14M
2.28M
1.12M
321.00K
Other non operating income
-115.00K
-30.00K
10.00K
9.00K
EBT including unusual items
1.00M
1.54M
1.13M
330.00K
EBT excluding unusual items
1.00M
2.24M
1.13M
330.00K
Income tax expense
-11.00K
-21.22M
302.00K
64.00K
Effective tax rate
-1.10%
-1,382.21%
26.65%
19.39%
Other operating expenses
-
-
-
-
Net income
911.00K
22.66M
721.00K
158.00K
Net profit margin
10.40%
245.63%
7.98%
1.73%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-30.00K
-12.00K
-
-
Net interest expenses
-30.00K
-12.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.26M
2.40M
1.24M
448.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps